Deficiency in Nucleotide Excision Repair Family Gene Activity, Especially ERCC3, Is Associated with Non-Pigmented Hair Fiber Growth

per Yu, Mei, Bell, Robert H., Ho, Maggie M., Leung, Gigi, Haegert, Anne, Carr, Nicholas, Shapiro, Jerry, McElwee, Kevin J.
Publicat 2012

Notch signaling is significantly suppressed in basal cell carcinomas and activation induces basal cell carcinoma cell apoptosis

per Shi, Feng-Tao, Yu, Mei, Zloty, David, Bell, Robert H., Wang, Eddy, Akhoundsadegh, Noushin, Leung, Gigi, Haegert, Anne, Carr, Nicholas, Shapiro, Jerry, McElwee, Kevin J.
Publicat a Mol Med Rep (2017)

miR-100-5p inhibition induces apoptosis in dormant prostate cancer cells and prevents the emergence of castration-resistant prostate cancer

per Nabavi, Noushin, Saidy, Nur Ridzwan Nur, Venalainen, Erik, Haegert, Anne, Parolia, Abhijit, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Dong, Xin, Collins, Colin, Crea, Francesco, Wang, Yuzhuo
Publicat a Sci Rep (2017)

Conditionally Reprogrammed Cells from Patient-Derived Xenograft to Model Neuroendocrine Prostate Cancer Development

per Ci, Xinpei, Hao, Jun, Dong, Xin, Xue, Hui, Wu, Rebecca, Choi, Stephen Yiu Chuen, Haegert, Anne M., Collins, Colin C., Liu, Xuefeng, Lin, Dong, Wang, Yuzhuo
Publicat a Cells (2020)

Well-Differentiated Papillary Mesothelioma of the Peritoneum Is Genetically Distinct from Malignant Mesothelioma

per Shrestha, Raunak, Nabavi, Noushin, Volik, Stanislav, Anderson, Shawn, Haegert, Anne, McConeghy, Brian, Sar, Funda, Brahmbhatt, Sonal, Bell, Robert, Le Bihan, Stephane, Wang, Yuzhuo, Collins, Colin, Churg, Andrew
Publicat a Cancers (Basel) (2020)

Patient-derived bladder cancer xenografts in the preclinical development of novel targeted therapies

per Jäger, Wolfgang, Xue, Hui, Hayashi, Tetsutaro, Janssen, Claudia, Awrey, Shannon, Wyatt, Alexander W., Anderson, Shawn, Moskalev, Igor, Haegert, Anne, Alshalalfa, Mohammed, Erho, Nicholas, Davicioni, Elai, Fazli, Ladan, Li, Estelle, Collins, Colin, Wang, Yuzhuo, Black, Peter C.
Publicat a Oncotarget (2015)

The retinoblastoma protein regulates hypoxia-inducible genetic programs, tumor cell invasiveness and neuroendocrine differentiation in prostate cancer cells

per Labrecque, Mark P., Takhar, Mandeep K., Nason, Rebecca, Santacruz, Stephanie, Tam, Kevin J., Massah, Shabnam, Haegert, Anne, Bell, Robert H., Altamirano-Dimas, Manuel, Collins, Colin C., Lee, Frank J.S., Prefontaine, Gratien G., Cox, Michael E., Beischlag, Timothy V.
Publicat a Oncotarget (2016)

Metabolic heterogeneity signature of primary treatment-naïve prostate cancer

per Lin, Dong, Ettinger, Susan L., Qu, Sifeng, Xue, Hui, Nabavi, Noushin, Chuen Choi, Stephen Yiu, Bell, Robert H., Mo, Fan, Haegert, Anne M., Gout, Peter W., Fleshner, Neil, Gleave, Martin E., Pollak, Michael, Collins, Colin C., Wang, Yuzhuo
Publicat a Oncotarget (2017)

Identification of DEK as a potential therapeutic target for neuroendocrine prostate cancer

per Lin, Dong, Dong, Xin, Wang, Kendric, Wyatt, Alexander W., Crea, Francesco, Xue, Hui, Wang, Yuwei, Wu, Rebecca, Bell, Robert H., Haegert, Anne, Brahmbhatt, Sonal, Hurtado-Coll, Antonio, Gout, Peter W., Fazli, Ladan, Gleave, Martin E., Collins, Colin C., Wang, Yuzhuo
Publicat a Oncotarget (2014)

Genomic alterations in cell-free DNA and enzalutamide resistance in castration-resistant prostate cancer

per Wyatt, Alexander W, Azad, Arun A, Volik, Stanislav V, Annala, Matti, Beja, Kevin, McConeghy, Brian, Haegert, Anne, Warner, Evan W, Mo, Fan, Brahmbhatt, Sonal, Shukin, Robert, Le Bihan, Stephane, Gleave, Martin E, Nykter, Matti, Collins, Colin C, Chi, Kim N
Publicat a JAMA Oncol (2016)

Germline CDH1 deletions in hereditary diffuse gastric cancer families

per Oliveira, Carla, Senz, Janine, Kaurah, Pardeep, Pinheiro, Hugo, Sanges, Remo, Haegert, Anne, Corso, Giovanni, Schouten, Jan, Fitzgerald, Rebecca, Vogelsang, Holger, Keller, Gisela, Dwerryhouse, Sarah, Grimmer, Donna, Chin, Suet-Feung, Yang, Han-Kwang, Jackson, Charles E., Seruca, Raquel, Roviello, Franco, Stupka, Elia, Caldas, Carlos, Huntsman, David
Publicat 2009

Next Generation Sequencing of Prostate Cancer from a Patient Identifies a Deficiency of Methylthioadenosine Phosphorylase (MTAP), an Exploitable Tumor Target

per Collins, Colin C, Volik, Stanislav V, Lapuk, Anna V, Wang, Yuwei, Gout, Peter W, Wu, Chunxiao, Xue, Hui, Cheng, Hongwei, Haegert, Anne, Bell, Robert H, Brahmbhatt, Sonal, Anderson, Shawn, Fazli, Ladan, Hurtado-Coll, Antonio, Rubin, Mark A., Demichelis, Francesca, Beltran, Himisha, Hirst, Martin, Marra, Marco, Maher, Christopher A., Chinnaiyan, Arul M., Gleave, Martin, Bertino, Joseph R., Lubin, Martin, Wang, Yuzhuo
Publicat 2012

Heterogeneity in the inter-tumor transcriptome of high risk prostate cancer

per Wyatt, Alexander W, Mo, Fan, Wang, Kendric, McConeghy, Brian, Brahmbhatt, Sonal, Jong, Lina, Mitchell, Devon M, Johnston, Rebecca L, Haegert, Anne, Li, Estelle, Liew, Janet, Yeung, Jake, Shrestha, Raunak, Lapuk, Anna V, McPherson, Andrew, Shukin, Robert, Bell, Robert H, Anderson, Shawn, Bishop, Jennifer, Hurtado-Coll, Antonio, Xiao, Hong, Chinnaiyan, Arul M, Mehra, Rohit, Lin, Dong, Wang, Yuzhuo, Fazli, Ladan, Gleave, Martin E, Volik, Stanislav V, Collins, Colin C
Publicat 2014

Integrated genome and transcriptome sequencing identifies a novel form of hybrid and aggressive prostate cancer

per Wu, Chunxiao, Wyatt, Alexander W, Lapuk, Anna V, McPherson, Andrew, McConeghy, Brian J, Bell, Robert H, Anderson, Shawn, Haegert, Anne, Brahmbhatt, Sonal, Shukin, Robert, Mo, Fan, Li, Estelle, Fazli, Ladan, Hurtado-Coll, Antonio, Jones, Edward C, Butterfield, Yaron S, Hach, Faraz, Hormozdiari, Fereydoun, Hajirasouliha, Iman, Boutros, Paul C, Bristow, Robert G, Jones, Steven JM, Hirst, Martin, Marra, Marco A, Maher, Christopher A, Chinnaiyan, Arul M, Sahinalp, S Cenk, Gleave, Martin E, Volik, Stanislav V, Collins, Colin C
Publicat 2012

BAP1 haploinsufficiency predicts a distinct immunogenic class of malignant peritoneal mesothelioma

per Shrestha, Raunak, Nabavi, Noushin, Lin, Yen-Yi, Mo, Fan, Anderson, Shawn, Volik, Stanislav, Adomat, Hans H., Lin, Dong, Xue, Hui, Dong, Xin, Shukin, Robert, Bell, Robert H., McConeghy, Brian, Haegert, Anne, Brahmbhatt, Sonal, Li, Estelle, Oo, Htoo Zarni, Hurtado-Coll, Antonio, Fazli, Ladan, Zhou, Joshua, McConnell, Yarrow, McCart, Andrea, Lowy, Andrew, Morin, Gregg B., Chen, Tianhui, Daugaard, Mads, Sahinalp, S. Cenk, Hach, Faraz, Le Bihan, Stephane, Gleave, Martin E., Wang, Yuzhuo, Churg, Andrew, Collins, Colin C.
Publicat a Genome Med (2019)

Stromal Gene Expression is Predictive for Metastatic Primary Prostate Cancer()

per Mo, Fan, Lin, Dong, Takhar, Mandeep, Ramnarine, Varune Rohan, Dong, Xin, Bell, Robert H., Volik, Stanislav V., Wang, Kendric, Xue, Hui, Wang, Yuwei, Haegert, Anne, Anderson, Shawn, Brahmbhatt, Sonal, Erho, Nicholas, Wang, Xinya, Gout, Peter W., Morris, James, Karnes, R. Jeffrey, Den, Robert B., Klein, Eric A., Schaeffer, Edward M., Ross, Ashley, Ren, Shancheng, Sahinalp, S. Cenk, Li, Yingrui, Xu, Xun, Wang, Jun, Wang, Jian, Gleave, Martin E., Davicioni, Elai, Sun, Yinghao, Wang, Yuzhuo, Collins, Colin C.
Publicat a Eur Urol (2017)

From sequence to molecular pathology, and a mechanism driving the neuroendocrine phenotype in prostate cancer

per Lapuk, Anna V, Wu, Chunxiao, Wyatt, Alexander W, McPherson, Andrew, McConeghy, Brian J, Brahmbhatt, Sonal, Mo, Fan, Zoubeidi, Amina, Anderson, Shawn, Bell, Robert H, Haegert, Anne, Shukin, Robert, Wang, Yuzhuo, Fazli, Ladan, Hurtado-Coll, Antonio, Jones, Edward C, Hach, Faraz, Hormozdiari, Fereydoun, Hajirasouliha, Iman, Boutros, Paul C, Bristow, Robert G, Zhao, Yongjun, Marra, Marco A, Fanjul, Andrea, Maher, Christopher A, Chinnaiyan, Arul M, Rubin, Mark A, Beltran, Himisha, Sahinalp, S Cenk, Gleave, Martin E, Volik, Stanislav V, Collins, Colin C
Publicat 2012